Sep 13, 2021 / 09:00PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
Good evening, everyone. Thanks for joining us on day 3 of our Healthcare Conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley.
Delighted to have Akoya join us today. And representing the company, we have Brian McKelligon, CEO; and Joe Driscoll, CFO. So welcome, gents. Before we get started, a quick disclosure statement to read. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures.
If you have any questions, please do reach out to your sales rep. So Brian, I mean, before we get into the weeds, I mean, just for folks not as familiar with the story, could you provide a brief overview of the history of the company, how the 2 parts of the portfolio sort of like came together. And a highlight what you view as some of the key milestones you've achieved over the last 12 months or so besides the IPO, of course.
Brian McKelligon - Akoya Biosciences, Inc. - President, CEO & Director
Akoya Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers